How we harmonize HSCT clinical practices among the SFGM-TC centers;Ateliers d'harmonisation des pratiques de la SFGM-TC

Bulletin du Cancer

Volumn 103, Issue 11, 2016, Pages S193-S197

  Tipton, Rachel ^a   Yakoub Agha, Ibrahim ^b  

^a SFGM TC   (France)

^b UNIVERSITÉ DE LILLE   (France)

Author keywords

Clinical practice; Harmonization; SFGM TC guidelines; Workshops

Indexed keywords

BONE MARROW TRANSPLANTATION; CELL THERAPY; CONSENSUS DEVELOPMENT; HUMAN; HUMAN TISSUE; PATIENT CARE; PRACTICE GUIDELINE; FRANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MEDICAL SOCIETY; STANDARDS;

CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; FRANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84999008893     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1016/j.bulcan.2016.09.006     Document Type: Article

References (25)

1. [1] Yakoub-Agha, I., [Fourth annual series of workshops of the SFGM-TC to harmonize practices in allogeneic stem cell transplantation]. Pathol Biol (Paris), 62(4), 2014, 179.
2. [2] Blaise, D., Nguyen, S., Bay, J.O., Chevallier, P., Contentin, N., Dhedin, N., et al. [Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 1)]. Pathol Biol (Paris) 62:4 (2014), 180–184.
3. [3] Nguyen, S., Blaise, D., Bay, J.O., Chevallier, P., Contentin, N., Dhedin, N., et al. [Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]. Pathol Biol (Paris) 62:4 (2014), 185–189.
4. [4] Farge, D., Terriou, L., Badoglio, M., Cras, A., Desreumaux, P., Hadj-Khelifa, S., et al. [Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC]. Pathol Biol (Paris) 62:4 (2014), 204–208.
5. [5] Calmels, B., Boulanger, F., Baudoux, E., Decot, V., Fawaz, A., Giraud, C., et al. [Conservation and destruction of autologous and allogeneic cryopreserved cellular products: recommendations from the SFGM-TC]. Pathol Biol (Paris) 62:4 (2014), 221–225.
6. [6] Bay, J.O., Peffault de Latour, R., Bruno, B., Coiteux, V., Guillaume, T., Hicheri, Y., et al. [Diagnosis and treatment of CMV and EBV reactivation as well as post-transplant lymphoproliferative disorders following allogeneic stem cell transplantation: an SFGM-TC report]. Pathol Biol (Paris) 61:4 (2013), 152–154.
7. [7] Deconinck, E., Dalle, J.H., Berceanu, A., Chevallier, P., Dulery, R., Garnier, A., et al. [How I manage respiratory syncytial virus, human herpesvirus 6 and adenovirus reactivation or infection after allogeneic stem cell transplantation: a report of the SFGM-TC]. Pathol Biol (Paris) 61:4 (2013), 149–151.
8. [8] Dulery, R., Giraud, C., Beaumont, J.L., Bilger, K., Borel, C., Dhedin, N., et al. [How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology test]. Pathol Biol (Paris) 61:4 (2013), 155–157.
9. [9] Dulery, R., Giraud, C., Beaumont, J.L., Bilger, K., Borel, C., Dhedin, N., et al. [How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant positive pregnancy test and monoclonal gammapathy]. Pathol Biol (Paris) 61:4 (2013), 158–159.
10. [10] Loiseau, P., Dubois, V., Bonafoux, B., Bulabois, C.E., Coiteux, V., Eliaou, J.F., et al. [Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC]. Pathol Biol (Paris) 62:4 (2014), 226–229.
11. [11] Choufi, B., Thiant, S., Trauet, J., Cliquennois, M., Cherrel, M., Boulanger, F., et al. [The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease]. Pathol Biol (Paris) 62:3 (2014), 123–128.
12. [12] Cornillon, J., Vantyghem, M.C., Couturier, M.A., de Berranger, E., Francois, S., Hermete, E., et al. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on adrenal insufficiency and osteoporosis]. Pathol Biol (Paris) 61:4 (2013), 171–173.
13. [13] Cornillon, J., Vantyghem, M.C., Couturier, M.A., de Berranger, E., Francois, S., Hermet, E., et al. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders]. Pathol Biol (Paris) 61:4 (2013), 168–170.
14. [14] Cornillon, J., Decanter, C., Couturier, M.A., de Berranger, E., Francois, S., Hermet, E., et al. [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on gonadal failure and fertility]. Pathol Biol (Paris) 61:4 (2013), 164–167.
15. [15] Vantyghem, M.C., Cornillon, J., Decanter, C., Defrance, F., Karrouz, W., Leroy, C., et al. Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation. Orphanet J Rare Dis, 9, 2014, 162.
16. [16] de Berranger, E., Michel, G., Fahd, M., Gandemer, V., Jubert, C., Marie-Cardine, A., et al. [Managing late-effects after allogeneic stem cell transplantation in children: recommendations from the SFGM-TC]. Pathol Biol (Paris) 62:4 (2014), 212–217.
17. [17] Guillaume, T., Porcheron, S., Audat, F., Bancillon, N., Berceanu, A., Charbonnier, A., et al. [Prophylactic, preemptive and curative use of donor lymphocyte infusion in patients undergoing allogeneic stem cell transplantation: guidelines of the SFGM-TC]. Pathol Biol (Paris) 62:4 (2014), 193–196.
18. [18] Wallart, A., Parguey, V., de Bentzmann, N., Bompoint, C., Fournier, I., Godin, S., et al. [A report of the SFGM-TC on the interactions between national transplant coordination and local coordinators in allogeneic stem cell transplantation activity]. Pathol Biol (Paris) 61:4 (2013), 144–146.
19. [19] Gauthier, J., Damaj, G., Yakoub-Agha, I., [The role of pre-transplant debulking treatment in patients undergoing allogeneic stem cell transplantation for high-risk myelodysplastic syndrome]. Bull Cancer 102:4 (2015), 340–348.
20. [20] Dalle, J.H., Donadieu, J., Paillard, C., Rialland, F., Schneider, P., Sicre De Fontbrune, F., et al. [SFGM-TC recommendation on indications for allogeneic stem cell transplantation in children with congenital neutropenia]. Pathol Biol (Paris) 62:4 (2014), 209–211.
21. [21] Rohrlich, P.S., Kerautret, K., Bancillon, N., Vauzelle, K., Bertrand-Letort, M., Ruiz, M., et al. [Social connection: a report of the SFGM-TC on the maintaining social and family connections during hematopoietic stem cell transplantation]. Pathol Biol (Paris) 61:4 (2013), 160–163.
22. [22] Cornillon, J., Peffault de Latour, R., Apaza, S., Bourg, M.A., Courbon, C., Evard, S., et al. [Transfer of skills: implementing post-transplant follow-up care status for transplant nurses: a report by the SFGM-TC]. Pathol Biol (Paris) 62:4 (2014), 190–192.
23. [23] Belaiche, S., Yafour, N., Balcaen, S., Beguin, Y., Borel, C., Bruno, B., et al. [Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC]. Pathol Biol (Paris) 62:4 (2014), 197–203.
24. [24] Rubio, M.T., Charbonnier, A., de Berranger, E., Gandemer, V., Magro, L., Maury, S., et al. [Vaccination post hematopoietic stem cell transplantation: which vaccines and when and, how to vaccinate? An SFGM-TC report]. Pathol Biol (Paris) 61:4 (2013), 139–143.
25. [25] De Vos, J., Birebent, B., Faucher, C., Giet, O., Hicheri, Y., Lemarie, C., et al. Quality controls on cord blood unit contiguous segments: recommendation of the SFGM-TC. Pathol Biol (Paris) 62:4 (2014), 218–220.